MEDICINOVA NEW DL-,001 revenue breakdown overview

MEDICINOVA NEW DL-,001 revenue for the last year amounted to 906.01 k EUR, the most of which — 906.01 k EUR — came from its highest performing source at the moment, Small Molecule Therapeutics, the year earlier bringing 3.55 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought MEDICINOVA NEW DL-,001 906.01 k EUR, and the year before that — 3.55 M EUR.